IGC Pharma (IGC) P/E (2011 - 2026)
IGC Pharma (IGC) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM IGC Pharma (IGC) P/E is -3.46. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of IGC Pharma (IGC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.46 | -5.15% |
| 2025 | -3.65 | +30.98% |
| 2024 | -2.79 | +95.09% |
| 2023 | -1.43 | +22.92% |
| 2022 | -1.16 | -72.56% |
| 2021 | -4.24 | -39.66% |
| 2020 | -7.02 | +61.86% |
| 2019 | -4.34 | +35.60% |
| 2018 | -3.20 | -79.39% |
| 2017 | -15.53 | +586.16% |
| 2016 | -2.26 | +105.86% |
| 2015 | -1.10 | -39.87% |
| 2014 | -1.83 | -71.92% |
| 2013 | -6.51 | +121.50% |
| 2012 | -2.94 | +1169.17% |
| 2011 | -0.23 | N/A |
Comparison IGC Pharma (IGC) P/E with competitors
IGC Pharma (IGC) P/E is -3.46.